| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $63.3M | — | -47.9% |
| Cost of Revenue | $25.4M | — | -53.0% |
| Gross Profit | $37.9M | — | -43.8% |
| R&D Expense | $9.1M | — | -68.9% |
| SG&A Expense | $19.2M | — | -51.3% |
| Operating Income | -$1.0M | — | +96.4% |
| Pre-tax Income | $88K | — | +100.5% |
| Income Tax | -$140K | — | -113.8% |
| Net Income | $228K | — | +101.3% |
| EPS (Basic) | $0.00 | — | +100.0% |
| EPS (Diluted) | $0.00 | — | +100.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $33.5M | +7.6% | -24.0% |
| Short-term Investments | $32.4M | -22.3% | -26.7% |
| Accounts Receivable | $17.8M | +14.0% | -37.7% |
| Current Assets | $110.8M | -8.9% | -47.2% |
| Total Assets | $244.1M | -12.2% | -44.4% |
| Current Liabilities | $106.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $4.1M | — | -83.3% |
| Capital Expenditures | $1.0M | — | -88.0% |
| Investing Cash Flow | $18.1M | — | -93.4% |
| Financing Cash Flow | -$20.0M | — | +95.2% |
| Free Cash Flow | $3.1M | — | -80.7% |
| -37.5% |
| Total Liabilities | $123.0M | -22.4% | -51.4% |
| Stockholders' Equity | $121.1M | +1.3% | -34.8% |